Schedule 13G ownership disclosure

CEREVEL THERAPEUTICS HLDNG I

Security class unavailable · CUSIP: 15678U128

Event date: 2020-11-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,639,190
Percent of class
2.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000080255-20-001736
Form type
SC 13G/A
Filer
Cerevel Therapeutics Holdings, Inc.
CIK
CIK 1805387
Filed
Dec 10, 2020
Reporting period
Nov 30, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub